ADVANCED BILIARY TRACT CANCER
Clinical trials for ADVANCED BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer: experimental drug nanvuranlat in final testing
Disease control Recruiting nowThis phase 3 trial tests a new drug called nanvuranlat in 480 adults with advanced biliary tract cancer that has worsened after prior treatment. Participants receive either nanvuranlat or one of several standard treatments. The main goal is to see if nanvuranlat helps people live…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 09:00 UTC
-
Supercharged immune cells take on bile duct cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new cell therapy for people with advanced biliary tract cancer (bile duct or gallbladder cancer) that has not responded to standard treatments. The therapy uses the patient's own immune T cells, enhanced with a protein called CD160 to better target …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for bile duct cancer: triple therapy tested in major trial
Disease control Recruiting nowThis study tests a new combination of drugs (SHR-8068, adebrelimab, and chemotherapy) against the current standard treatment for advanced bile duct cancer. About 604 people with inoperable cancer who haven't had prior treatment will take part. The goal is to see if the new combo …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy hopes to tackle tough bile duct cancer
Disease control Recruiting nowThis phase 2 trial is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy or the targeted drug lenvatinib can help people with advanced biliary tract cancer live longer and control their tumors better. The study will enroll 60 adults whose cancer …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC